AAAAAA
Results: 51-75/140
Authors:
BOUSSIOTIS VA
PARDO NA
COLLINS H
HOUGHTON A
RITZ J
NADLER LM
SOIFFER RJ
Citation: Va. Boussiotis et al., R24 ANTI-GD3 GANGLIOSIDE ANTIBODY CAN INDUCE CO-STIMULATION AND PREVENT THE INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL CLONAL ANERGY, European Journal of Immunology, 26(9), 1996, pp. 2149-2154
Authors:
FREEDMAN AS
GRIBBEN JG
NEUBERG D
MAUCH P
SOIFFER RJ
ANDERSON KC
PANDITE L
ROBERTSON MJ
KROON M
RITZ J
NADLER LM
Citation: As. Freedman et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING FIRST REMISSION, Blood, 88(7), 1996, pp. 2780-2786
Authors:
PROVAN D
BARTLETTPANDITE L
ZWICKY C
NEUBERG D
MADDOCKS A
CORRADINI P
SOIFFER R
RITZ J
NADLER LM
GRIBBEN JG
Citation: D. Provan et al., ERADICATION OF POLYMERASE CHAIN REACTION-DETECTABLE CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS IS ASSOCIATED WITH IMPROVED OUTCOME AFTER BONE-MARROW TRANSPLANTATION, Blood, 88(6), 1996, pp. 2228-2235
Authors:
PIGNATA C
SANGHERA JS
SOIFFER RJ
CHARTIER S
EDER M
PELECH SL
RITZ J
Citation: C. Pignata et al., DEFECTIVE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(6), 1996, pp. 2334-2341
Authors:
MCLEAN TW
RINGOLD S
NEUBERG D
STEGMAIER K
TANTRAVAHI R
RITZ J
KOEFFLER HP
TAKEUCHI S
JANSSEN JWG
SERIU T
BARTRAM CR
SALLAN SE
GILLILAND DG
GOLUB TR
Citation: Tw. Mclean et al., TEL AML-1 DIMERIZES AND IS ASSOCIATED WITH A FAVORABLE OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA/, Blood, 88(11), 1996, pp. 4252-4258
Authors:
ORSINI E
CLARET EJ
ALYEA EP
SCHLOSSMAN R
CANNING C
SOIFFER RJ
ANDERSON KC
RITZ J
Citation: E. Orsini et al., DISTINCT CHANGES IN T-CELL REPERTOIRE ASSOCIATED WITH GVL AND GVHD INPATIENTS RECEIVING DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1020-1020
Authors:
ALYEA EP
SCHLOSSMAN RL
CANNING C
COLLINS H
PICKETT C
WANG Y
SOIFFER RJ
ANDERSON KC
RITZ J
Citation: Ep. Alyea et al., CD8-DEPLETED DONOR LYMPHOCYTE INFUSIONS MEDIATE GRAFT VERSUS MULTIPLE-MYELOMA (MM) EFFECT, Blood, 88(10), 1996, pp. 1021-1021
Authors:
VANCE EU
FLEMING M
RITZ J
SOIFFER RJ
Citation: Eu. Vance et al., OUTCOME OF LYMPHOPROLIFERATIVE DISEASE FOLLOWING CD6 T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 1033-1033
Authors:
GOLLOB JA
MAHAJAN S
RUDDERS SA
RITZ J
FRANK DA
Citation: Ja. Gollob et al., IFN-GAMMA AND IL-4 PROMOTE TH1 AND TH2 DEVELOPMENT BY DIFFERENTIALLY MODULATING HIGH-AFFINITY IL-12 RECEPTOR EXPRESSION AND IL-12-INDUCED ACTIVATION OF STAT1 AND STAT5, Blood, 88(10), 1996, pp. 1100-1100
Authors:
MAHAJAN S
RUDDERS SA
RITZ J
FRANK DA
Citation: S. Mahajan et al., LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA CONTAIN STAT1 AND STAT3 CONSTITUTIVELY PHOSPHORYLATED ON SERINE, Blood, 88(10), 1996, pp. 1171-1171
Authors:
SOIFFER RJ
COLLINS H
RITZ J
Citation: Rj. Soiffer et al., DEFECTIVE GD3 GANGLIOSIDE (CDW60) MEDIATED T-CELL RESPONSE FOLLOWING T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1192-1192
Authors:
WEBB IJ
SOIFFER RJ
ANDERSEN JW
COHEN CA
FREEMAN A
SUGRUE M
RITZ J
ANDERSON KC
Citation: Ij. Webb et al., FFP TO ADSORB ISOHEMAGGLUTININS PRIOR TO MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1823-1823
Authors:
ALYEA EP
CANNING C
COLLINS H
PICKETT C
WANG Y
SOIFFER RJ
RITZ J
Citation: Ep. Alyea et al., EFFICACY AND TOXICITY OF CD4-LYMPHOCYTE INFUSION FOR TREATMENT OF RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER ALLOGENEIC BMT( DONOR T), Blood, 88(10), 1996, pp. 2715-2715
Authors:
BARTLETTPANDITE L
GRIBBEN JG
SOIFFER R
ANDERSEN NS
ANDERSON K
FISHER DC
FREEDMAN AS
RITZ J
NEUBERG D
NADLER LM
Citation: L. Bartlettpandite et al., POTENTIAL FOR CURE OF B-CELL CLL AND SLL - PROLONGED DISEASE-FREE SURVIVAL AND MOLECULAR REMISSIONS FOLLOWING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2718-2718
Authors:
SOIFFER RJ
NEUBERG D
FREEDMAN AS
ALYEA EP
FISHER DC
BARTLETTPANDITE L
GRIBBEN J
SCHLOSSMAN RL
FREEMAN A
ANDERSON KC
NADLER LM
RITZ J
Citation: Rj. Soiffer et al., CD6 DEPLETED ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 2719-2719
Authors:
SCHUMANN RR
NAKARAI T
GRUSS HJ
BRACH MA
VONARNIM U
KIRSCHNING C
KARAWAJEW L
LUDWIG WD
RENAULD JC
RITZ J
HERRMANN F
Citation: Rr. Schumann et al., TRANSCRIPT SYNTHESIS AND SURFACE EXPRESSION OF THE INTERLEUKIN-2 RECEPTOR (ALPHA-CHAIN, BETA-CHAIN, AND GAMMA-CHAIN) BY NORMAL AND MALIGNANT MYELOID CELLS, Blood, 87(6), 1996, pp. 2419-2427
Authors:
NGUYEN PL
HARRIS NL
RITZ J
ROBERTSON MJ
Citation: Pl. Nguyen et al., EXPRESSION OF CD95 ANTIGEN AND BCL-2 PROTEIN IN NON-HODGKINS-LYMPHOMAS AND HODGKINS-DISEASE, The American journal of pathology, 148(3), 1996, pp. 847-853
Authors:
WANG DK
RITZ J
ROBERTSON MJ
Citation: Dk. Wang et al., CHARACTERIZATION OF CD95 MONOCLONAL-ANTIBODIES - EPITOPE SPECIFICITIES AND FUNCTIONAL-EFFECTS, Tissue antigens, 48(4-II), 1996, pp. 602-602
Authors:
WANG DK
RITZ J
ROBERTSON MJ
Citation: Dk. Wang et al., EXPRESSION OF TNF RECEPTOR SUPERFAMILY MEMBERS AND IL-1 RECEPTORS BY NATURAL-KILLER-CELLS, Tissue antigens, 48(4-II), 1996, pp. 608-608
Authors:
ROBERTSON MJ
MANLEY TJ
PICHERT G
CAMERON C
COCHRAN KJ
LEVINE H
RITZ J
Citation: Mj. Robertson et al., FUNCTIONAL CONSEQUENCES OF APO-1 FAS (CD95) ANTIGEN EXPRESSION BY NORMAL AND NEOPLASTIC HEMATOPOIETIC-CELLS/, Leukemia & lymphoma, 17(1-2), 1995, pp. 51-61
Authors:
SEIDEN MV
SCHLOSSMAN R
ANDERSEN J
FREEMAN A
ROBERTSON M
SOIFFER R
FREEDMAN A
MAUCH P
RITZ J
NADLER L
ANDERSON KC
Citation: Mv. Seiden et al., MONOCLONAL ANTIBODY-PURGED BONE-MARROW TRANSPLANTATION THERAPY FOR MULTIPLE-MYELOMA, Leukemia & lymphoma, 17(1-2), 1995, pp. 87-93
Authors:
SOIFFER RJ
ALYEA EP
RITZ J
Citation: Rj. Soiffer et al., IMMUNOMODULATORY EFFECTS OF DONOR LYMPHOCYTE INFUSIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical apheresis, 10(3), 1995, pp. 139-143
Authors:
PICHERT G
ROY DC
GONIN R
ALYEA EP
BELANGER R
GYGER M
PERREAULT C
BONNY Y
LERRA I
MURRAY C
SOIFFER RJ
RITZ J
Citation: G. Pichert et al., DISTINCT PATTERNS OF MINIMAL RESIDUAL DISEASE-ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 13(7), 1995, pp. 1704-1713
Authors:
LEW MA
KEHOE K
RITZ J
ANTMAN KH
NADLER L
KALISH LA
FINBERG R
Citation: Ma. Lew et al., CIPROFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OFBACTERIAL-INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS - A RANDOMIZED, CONTROLLED TRIAL, Journal of clinical oncology, 13(1), 1995, pp. 239-250
Authors:
ROY DC
PERREAULT C
BELANGER R
GYGER M
LEHOUILLIER C
BLATTLER WA
LAMBERT JM
RITZ J
Citation: Dc. Roy et al., ELIMINATION OF B-LINEAGE LEUKEMIA AND LYMPHOMA-CELLS FROM BONE-MARROWGRAFTS USING ANTI-B4-BLOCKED-RICIN IMMUNOTOXIN, Journal of clinical immunology, 15(1), 1995, pp. 51-57